300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oceania
LATAM
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Sudan
Andorra
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Morocco
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Ireland
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology Angel Investors in France (September 2026)

The most active angel investors investing in France Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in France Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Bernard Majoie
Angel
5 France, Belgium Seed, Pre-Seed, Series A Biotechnology, Medical, Health Care $1.4M–$2.7M
Romain Sautrau
Angel
3 France, Denmark Series A, Seed, Pre-Seed Biotechnology, Farming, Agriculture $1.1M–$12M
Sake Bosch
Angel
3 The Netherlands, France, Israel Seed, Series A, Series B Software, E-Commerce, Biotechnology $1.3M–$77M
Andrew Nutter
Angel
2 France, United Kingdom, United States Seed, Pre-Seed, Venture - Series Unknown Software, SaaS, FinTech $550k–$4.9M
Raphaël Varane
Angel
2 France, Portugal, United Kingdom Seed, Series A, Series B Sports, Artificial Intelligence, Apps $5M–$9.2M
Nicolas Douay
Angel
2 France, United States, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $500k–$14M
Xavier Niel
Angel
2 France, United States Seed, Series A, Pre-Seed Artificial Intelligence, Software, Analytics $2.3M–$113M
Thomas France
Angel
2 France, United States, Cayman Islands Seed, Pre-Seed, Series A Blockchain, Web3, Information Technology $400k–$31M
Alain Sainsot
Angel
2 France Seed, Private Equity Biotechnology, Medical, Wellness
Jean Pierre Arnaud
Angel
2 France Seed, Private Equity Biotechnology, Medical, Wellness
André-Jacques Auberton-Hervé
Angel
2 France Seed, Series A Medical, Biotechnology
Sylvain Zimmer
Angel
2 France, United States, United Kingdom Seed, Pre-Seed, Angel Software, SaaS, Real Estate $200k–$10M
Octave Klaba
Angel
2 France, Belgium Seed, Angel, Series A Biotechnology, Machine Learning, Artificial Intelligence $2.2M–$17M
Nicolas Godin
Angel
2 France, United States Pre-Seed Health Care, Biotechnology, Machine Learning
Bertrand Jacquelot
Angel
2 France, United States Pre-Seed, Seed, Angel Food and Beverage, E-Commerce, Information Technology $120k–$7.8M
Alexandre Yazdi
Angel
2 France, Portugal, Turkey Seed, Pre-Seed, Series A Software, Gaming, Artificial Intelligence $1.1M–$31M
Flavien Kulawik
Angel
1 France, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, Health Care $1.3M–$7M
Geoffrey Duyk
Angel
1 United States, Japan, France Series A, Series B, Series C Biotechnology, Medical, Chemical $10M–$100M
Giorgio Anania
Angel
1 France Seed Medical, Biotechnology
Julien Lopizzo
Angel
1 France Seed, Pre-Seed, Series A Legal Tech, Advertising, Digital Media $2.4M–$6.1M
Pierre Olivier Goineau
Angel
1 France Venture - Series Unknown Medical, Biopharma, Health Care
Gregoire Delpit
Angel
1 France Pre-Seed, Seed Software, Apps, SaaS
Tom Kemp
Angel
1 United States, France, Israel Seed, Pre-Seed Cyber Security, Software, Network Security $932k–$4M
Sebastien Breteau
Angel
1 United States, France, United Kingdom Seed, Series A, Angel FinTech, Software, Apps $500k–$150M
David Lamond
Angel
1 France, United States Series A Retail, Genetics, E-Commerce
David Helgason
Angel
1 United States, Denmark, Finland Seed, Series A, Pre-Seed Software, Gaming, Artificial Intelligence $242k–$30M
Olivier Duha
Angel
1 France Seed, Pre-Seed, Series A FinTech, Insurance, Consulting
Christophe Cervasel
Angel
1 France Seed Farming, Medical, Wellness $1.3M–$1.4M
Eric Carreel
Angel
1 France Seed, Pre-Seed, Series A Data Center, Electronics, Data Storage
Alain Tingaud
Angel
1 France, Luxembourg, United States Pre-Seed, Seed Software, E-Commerce, Cryptocurrency $1.1M–$5M
Maxime Hurtebize
Angel
1 France Seed CleanTech, Electronics, Health Care
Charles-Edouard Bouee
Angel
1 United States, France, Vietnam Pre-Seed, Seed, Angel Biotechnology, Natural Resources, AgTech $348k–$1.2M
Lara Nuchowicz
Angel
1 France Pre-Seed Biotechnology, Product Research, Consumer Research
Andreï Polukhtin
Angel
1 France Biopharma, Biotechnology
Fidji Simo
Angel
1 United States, United Kingdom, Canada Seed, Series A, Series B Software, Health Care, Internet $1.2M–$250M
Cyril Grislain
Angel
1 France Series A, Seed, Angel Big Data, Software, Artificial Intelligence $1.3M–$9.1M
Arthur Waller
Angel
1 France, Spain, United States Seed, Series A, Pre-Seed Software, FinTech, Information Technology $1.4M–$21M
Rajat Khare
Angel
1 France, Switzerland, Germany Series A, Series B, Seed Drones, Aerospace, Artificial Intelligence
Khaled Helioui
Angel
1 United States, United Kingdom, Germany Series A, Seed, Series B Information Technology, Internet, Software $1.4M–$158M
Fabio Mondini de Focatiis
Angel
1 Italy, France, United Kingdom Seed, Pre-Seed, Equity Crowdfunding E-Commerce, Retail, Internet $318k–$3.3M
Rémi Gaston- Dreyfus
Angel
1 France Seed Medical, Biotechnology
Jean-Paul Kress
Angel
1 France Seed Medical, Biotechnology
Guillaume Amblard
Angel
1 France, United Kingdom, Tunisia Seed, Series A Software, Banking, FinTech $630k–$9M
Alexandre Prot
Angel
1 France, Singapore, Switzerland Seed, Series A, Series B FinTech, Financial Services, Banking $1.1M–$58M
Bertrand Jelensperger
Angel
1 France, Spain, Belgium Seed, Series A, Angel Apps, Software, E-Commerce $1M–$11M
Jacques Lewiner
Angel
1 France Seed, Series C Biotechnology, Medical, Health Care
Jacques Gardette
Angel
1 France Series A Software, Biotechnology, Medical Device
Bashar Hamood
Angel
1 United States, Nigeria, United Kingdom Seed, Pre-Seed, Series A Information Technology, Software, E-Commerce
Stephane Legastelois
Angel
1 France Series A Biotechnology, Pharmaceutical
Geoffroy Roux de Bezieux
Angel
1 France Seed, Series A, Pre-Seed Software, Mobile Apps, Real Estate $2.8M–$5.3M
Access all 90 angel investors in France Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Bernard Majoie
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 5 investments in France Biotechnology startups

Bernard Majoie - President @ Fournier-Majoie

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 6
  • Round size: Seed $1.4M–$2.7M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • reMYND — Driving the development of disease-modifying treatments
  • AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
  • PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Show all investments...

Romain Sautrau
Angel · Paris, Ile-de-France, France · 3 investments in France Biotechnology startups

Romain Sautrau is a Investment Director at Supernova Invest. Romain attended INSEAD.

Show more...

Investment focus

  • Industry: Biotechnology, Farming, Agriculture
  • Stage:Series A, Seed, Pre-Seed
  • Geography: France, Denmark

Investor stats

  • Total investments: 13
  • Round size: Seed $1.4M–$2.7M; Series A $1.1M–$12M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Novolyze — Novolyze is a Food Safety company. They offer solutions to help the food industry manufacture safer food, while ensuring strong compliance with international Food Safety & Quality standards. Their research work mainly focuses on evaluating the inactivation of foodborne pathogens under different kinds of stress (heat, etc.). Based on thisexpertise, they have developed the first range of dried, ready-to-use surrogate bacteria, an innovation that allows the food industry to test the efficacy of microbial kill steps / intervention steps in real-life conditions. At Novolyze, they are at the forefront of Food Safety. Their cross-functional team of experts, mainly composed of food microbiologists and process engineers, is able to assist at multiple stages of a project. Novolyze relies on state-of-the-art infrastructures, installed in a pharmaceutical-grade environment at their R&D Center in Dijon, France.
  • Antofenol — Antofénol is a post-harvest biocontrol company that directs and develops its work on the valorization of viticultural waste. Antofénol is an innovative biotechnology start-up providing ecological eco-extraction of plant matter.
  • nextProtein — nextProtein is developing a large scale and sustainable insect based source of protein. The bioconversion of fly larvae fed with organic waste generates valuable feed components for fish, livestock and pets.
Show all investments...

Sake Bosch
Angel · Amsterdam, Noord-Holland, The Netherlands · 3 investments in France Biotechnology startups

Sake Bosch is a Founder and Managing Partner of Prime Ventures since 1999. Sake brings over 25 years of experience in marketing and sales and venture capital to Prime. Prior to founding Prime in 1999, Sake was a Senior Principal at Holland Venture and was responsible for managing investments in technology companies. Sake was involved in many ofthe Holland Venture technology investments including Applicare Medical Imaging (acquired by GE Medical Systems), BWise (acquired by Nasdaq), SQL Systems (acquired by Datastream) and Freecom (acquired by Mitsubishi Kagaku Media). Before joining Holland Venture in 1994, Sake worked as an Independent Corporate Finance Consultant focusing primarily on early stage companies. Prior to this position Sake was a Sales Executive at Securitas Group. Sake started his career in 1989 as a Strategic Market Analyst at VNU. Sake serves on the board of directors of Civolution, 4C, Dealerdirect, Digital Origin, Greetz, Forcare, SaaSPlaza, SlimPay and Takeaway.com. Previous investments include: 3mensio Medical Imaging (acquired by Esaoto), eBuddy (acquired by Booking.com), Global Collect (acquired by General Atlantic), MarketXS (acquired by Markit), Nedstat (acquired by comScore Inc.), Tridion (acquired by SDL) and Watermark (acquired by Qurius). Sake holds an M.Sc. degree in Business Administration as well as a B.A. degree in Management Science and Industrial Engineering.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: The Netherlands, France, Israel

Investor stats

  • Total investments: 33
  • Round size: Seed $1.3M–$7.2M; Series A $6.9M–$29M; Series B $7.1M–$77M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Alfa AI — Alfa AI is a recruitment technology company specializing in AI-driven hiring solutions.
  • TerraSpark — TerraSpark Energy specializing in software solutions for renewable energy asset management. The product, TerraSpark Hub, provides comprehensive oversight of commercial and technical data for green energy assets like solar and wind projects.
  • Recupere Metals — Recupere Metals focused on recycling copper scrap into high-quality electrical wires. It uses a patented mechanical process enhanced by AI to boost conductivity from impure scrap, bypassing energy-intensive smelting.
Show all investments...

Andrew Nutter
Angel · Paris, Ile-de-France, France · 2 investments in France Biotechnology startups

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: France, United Kingdom, United States

Investor stats

  • Total investments: 26
  • Round size: Seed $550k–$4.9M; Pre-Seed $902k–$3.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Yavin — Yavin provides modern point-of-sale solutions for European merchants. Yavin is a tool to receive payments, sell smarter, and grow the business.
  • Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
  • EV Biotech — DANU strain engineering creates Precision Biopolymers For High-Performance Applications through strain engineering and AI.
Show all investments...

Raphaël Varane
Angel · 2 investments in France Biotechnology startups

Raphaël Varane is a French professional footballer who plays as a centre-back for Premier League club Manchester United and the France national team.

Show more...

Investment focus

  • Industry: Sports, Artificial Intelligence, Apps
  • Stage:Seed, Series A, Series B
  • Geography: France, Portugal, United Kingdom

Investor stats

  • Total investments: 7
  • Round size: Seed $5M–$9.2M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • MORFO — We combine local seeds, biological symbioses, drones and artificial intelligence to sustainably reforest and fight global warming around the world.
  • REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
  • Docent — Docent is the first AI-powered mobile application to offer a fully-personalized experience for discovering, accessing and collecting contemporary masterpieces.
Show all investments...

Nicolas Douay
Angel · Paris, Ile-de-France, France · 2 investments in France Biotechnology startups

Previously cofounder @ Keldoc - currently early stage investor @ Better Angle

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 60
  • Round size: Seed $768k–$5.5M; Pre-Seed $500k–$8.6M; Series A $6.8M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bealy health — Discover personalized healthcare at Bealy Medical. Our expert physicians deliver tailored consultations, comprehensive treatment plans, and innovative medical solutions, ensuring optimal health outcomes through patient-centered care and advanced medical expertise.
  • Djamo — Djamo is a Provider of financial applications to allow customers to use their cards with zero fees in a wide range of services.
  • underdog — underdog is a simplified & refurbished household appliances.
Show all investments...

Xavier Niel
Angel · Paris, Ile-de-France, France · 2 investments in France Biotechnology startups

Xavier Niel is based out of Paris, Ile-de-France and is the Co-Founder and CEO of NJJ Capital. Xavier previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Analytics
  • Stage:Seed, Series A, Pre-Seed
  • Geography: France, United States

Investor stats

  • Total investments: 14
  • Round size: Seed $7.5M–$113M; Pre-Seed $3.5M–$3.8M; Series A $2.3M–$100M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
  • Genesis AI — Genesis AI operates as a physical AI lab and full-stack robotics company.
  • Mobile Club — Mobile.club is a smartphone rental without obligation.
Show all investments...

Thomas France
Angel · San Francisco, California, United States · 2 investments in France Biotechnology startups

Entrepreneur, Investor

Show more...

Investment focus

  • Industry: Blockchain, Web3, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, United States, Cayman Islands

Investor stats

  • Total investments: 23
  • Round size: Seed $2.1M–$15M; Pre-Seed $400k–$7.2M; Series A $2.8M–$31M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Keplr — Introducing the first, and leading, IBC-enabled wallet for Cosmos and beyond
  • Reppo Labs — Blockchain Network that connect Data Owners with AI Developers and AI agents through Programmable IP Co-ownership
  • Belfort — Enabling Fully Homomorphic Encryption through Hardware Acceleration
Show all investments...

Alain Sainsot
Angel · Toulouse, Midi-Pyrenees, France · 2 investments in France Biotechnology startups

Alain Sainsot is the current President and Chief Executive Officer of GTP Bioways. He previously worked at AMATSIGROUP as a President. Alain Sainsot attended ISG Higher Institute of Management.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Wellness
  • Stage:Seed, Private Equity
  • Geography: France

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Vectalys — As the lentiviral manufacturing platform of Flash Therapeutics, Vectalys produces both non-integrative (LentiFlash) and integrative lentiviral vectors from R&D to GMP grade.
  • Flash Therapeutics — Trusted provider of lentiviral vectors for discovery & clinical grade. Discover the manufacturing services of viral vectors for RUO or GMP.
Show all investments...

Jean Pierre Arnaud
Angel · 2 investments in France Biotechnology startups

Jean Pierre Arnaud received his D.V.M. from the National Veterinary School of Maison-Alfort, France, then got a certificate in Nutrition for food-production animals (CSAAD) and a specialization in poultry production from the National School of Agronomics of Paris-Grignon, he also got a certificate in Statistics from University of Paris VI. Heco-founded Avogadro in May 1998 after having worked ten years at Rhone Merieux/Merial starting as clinician and finally as Manager of the Drug Safety Department.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Wellness
  • Stage:Seed, Private Equity
  • Geography: France

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Vectalys — As the lentiviral manufacturing platform of Flash Therapeutics, Vectalys produces both non-integrative (LentiFlash) and integrative lentiviral vectors from R&D to GMP grade.
  • Flash Therapeutics — Trusted provider of lentiviral vectors for discovery & clinical grade. Discover the manufacturing services of viral vectors for RUO or GMP.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
André-Jacques Auberton-Hervé
Angel · Grenoble, Rhone-Alpes, France · 2 investments in France Biotechnology startups

Dr. André-Jacques Auberton-Hervé co-founded Soitec with Jean-Michel Lamure in 1992. As President, CEO and Chairman of the Board, Auberton-Hervé is responsible for overseeing the strategic, operational and financial activities of the company.Prior to founding Soitec, Auberton-Hervé managed several joint development programs between Leti andThomson-CSF, which focused on the technological transfer from R&D to production applications. These programs included the transfer of 1.2 µm and 0.8 µm SOI CMOS for space applications. He was also in charge of several projects, which applied SOI to 3D integration, VLSI and ULSI.In July of 2005, Auberton-Hervé was elected to serve as the European representative to SEMI’s International Board of Directors. His demonstrated vision, experience and leadership capabilities within the industry contributed to his appointment to the board. Auberton-Hervé is also the recipient of the 1999 European SEMI Award in recognition of his work on Smart Cut™ technology and his overall contributions to the semiconductor industry as a whole. Auberton-Hervé is a member of the Electrochemical Society and the IEEE.

Show more...

Investment focus

  • Industry: Medical, Biotechnology
  • Stage:Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Show all investments...

Sylvain Zimmer
Angel · Paris, Ile-de-France, France · 2 investments in France Biotechnology startups

Sylvain Zimmer is based out of Paris, Ile-de-France and is the Chief Technology Officer of La Suite territoriale (EIG) of Direction interministérielle du numérique. Sylvain previously worked at Contentsquare as a head of the CTO office. Sylvain Zimmer attended the National School of Computer Science and Applied Mathematics of Grenoble.

Show more...

Investment focus

  • Industry: Software, SaaS, Real Estate
  • Stage:Seed, Pre-Seed, Angel
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 26
  • Round size: Seed $740k–$10M; Angel $400k–$500k; Pre-Seed $200k–$2.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
  • Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
  • TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Show all investments...

Octave Klaba
Angel · Hanover, Niedersachsen, Germany · 2 investments in France Biotechnology startups

Octave Klaba is based out of Roubaix, Nord-Pas-de-Calais, and is the Chairman and CEO of OVH cloud. Octave Klaba attended the Icam - Institut Catholique d'Arts et Métiers.

Show more...

Investment focus

  • Industry: Biotechnology, Machine Learning, Artificial Intelligence
  • Stage:Seed, Angel, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 10
  • Round size: Seed $2.2M–$17M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
  • Aerospacelab — Aerospacelab makes access to space simple. By combining our satellite platforms with mission payloads, Aerospacelab is able to deliver end-to-end satellite solutions tailored to meet your business needs.
  • Qubit Pharmaceuticals — We work alongside biopharmas to transform the way drugs are developed by moving from approximation to prediction.
Show all investments...

Nicolas Godin
Angel · Paris, Ile-de-France, France · 2 investments in France Biotechnology startups

In addition to managing the company’s finances, Nicolas is responsible for Cardiologs’ operations and is a key voice on a variety of strategic and operational matters. Nicolas holds an MSc in Civil Engineering and an MBA from INSEAD, and started his career at PwC Transaction Services, working intensively on large European M&A deals. After anexperience at a VC fund in Paris, he joined the EdTech startup Coorpacademy, where he managed a Series B fundraising and transformed the company into a true SaaS business. Excited by the cross-functional nature of his role, Nicolas brings operational and financial excellence to Cardiologs.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Machine Learning
  • Stage:Pre-Seed
  • Geography: France, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Surge — SurgeCare leverages immune profiling and AI to reveal early immune signatures and drive better decisions in surgery, trauma, infection, and beyond.
  • Surge — SurgeCare leverages immune profiling and AI to reveal early immune signatures and drive better decisions in surgery, trauma, infection, and beyond.
Show all investments...

Bertrand Jacquelot
Angel · Paris, Ile-de-France, France · 2 investments in France Biotechnology startups

Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.

Show more...

Investment focus

  • Industry: Food and Beverage, E-Commerce, Information Technology
  • Stage:Pre-Seed, Seed, Angel
  • Geography: France, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $1.5M–$7.8M; Pre-Seed $120k–$1.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
  • Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
  • Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Show all investments...

Alexandre Yazdi
Angel · 2 investments in France Biotechnology startups

Alexandre Yazdi is the CEO at Voodoo.

Show more...

Investment focus

  • Industry: Software, Gaming, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, Portugal, Turkey

Investor stats

  • Total investments: 22
  • Round size: Seed $1.1M–$11M; Pre-Seed $1.6M–$3.5M; Series A $2.3M–$31M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Plakar — Plakar is an open-source backup and restore platform built for modern infrastructure, AI workflows, and high-compliance environments.Designed to replace legacy backup systems with something leaner, smarter, and more developer-friendly, Plakar lets teams protect, version, and instantly recover their data — across local systems, S3-compatibleobject storage, Kubernetes, and more.Plakar turns every backup into a self-contained, immutable unit that carries its own structure, metadata, and encryption. It supports end-to-end deduplication, instant recovery, and granular restores, making backup storage reusable for AI training, data audits, and reproducibility.Plakar is especially relevant for teams working in fast-moving or regulated industries — such as AI, finance, healthcare, and cybersecurity — where data integrity, traceability, and rollback capabilities are mission-critical.Founded in 2024 and based in Paris, Plakar is backed by Seedcamp, HelloWorld, IrregularExpression, Galion.exe, Kima Ventures, OPRTRS, Purple, Motier Ventures, Pareto, and several leading angels including executives from Datadog, Docker, Voodoo, Sqreen, and Logmatic.io.
  • Alpa — Alpa connects to your till and bank to give restaurants a live P&L, cash flow, delivery commissions, supplier spend and a plain-English Monday briefing.
  • Revox — Revox appelle vos prospects, les qualifie, prend les rendez-vous et synchronise tout dans votre CRM.
Show all investments...

Flavien Kulawik
Angel · London, England, United Kingdom · 1 investments in France Biotechnology startups

Flavien Kulawik

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France, United Kingdom

Investor stats

  • Total investments: 14
  • Round size: Seed $1.3M–$7M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Claimy — Integrate Claimy to unlock the full potential of your catalogue, recover missing royalties, and gain real-time insights into your performances.
  • HrFlow.ai — Meet the first AI agents and Foundation models trained on billions of interview outcomes. The Hiring SuperIntelligence predicts your next hires and who's worth meeting, saving managers thousands of hours wasted on false positives.
  • Piston — Piston is the first Agentic ERP that thinks, advises, and executes tasks autonomously, so revenue grows while your team stays lean.
Show all investments...

Geoffrey Duyk
Angel · Tampa, Florida, United States · 1 investments in France Biotechnology startups

Dr. Geoffrey Duyk was a member of the Board from May 2006 through May 2011, and re-joined the Board in May 2012. Dr. Duyk is a partner of TPG Growth, LLC, an affiliate of TPG Biotechnology Partners II, L.P.Previously, he served on the board of directors and was President of Research and Development at Exelixis, Inc., a biopharmaceutical companyfocusing on drug discovery, from 1996 to 2003.Prior to Exelixis, Dr. Duyk was Vice President of Genomics and one of the founding scientific staff at Millennium Pharmaceuticals, from 1993 to 1996.Before that, Dr. Duyk was an Assistant Professor at Harvard Medical School in the Department of Genetics and Assistant Investigator of the Howard Hughes Medical Institute.Dr. Duyk currently serves on the boards of directors of several private companies and the non-profit Wesleyan University Board of Trustees. He served on the board of directors of Agria Corporation from August 2007 to May 2009, Cardiovascular Systems, Inc. (formerly Replidyne, Inc.) from 2004 to February 2009, Exelixis, Inc. from 1996 to 2003. Dr. Duyk holds a Bachelor of Arts degree in Biology from Wesleyan University and Doctor of Philosophy and Medicine degrees from Case Western Reserve University.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Chemical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Japan, France

Investor stats

  • Total investments: 11
  • Round size: Series A $10M–$20M; Series B $15M–$70M; Series C $15M–$100M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • DNAnexus — The world's most secure & trusted biomedical cloud platform that accelerates clinical and scientific discovery with the potential to improve patient lives.
  • LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
  • Aerie Pharmaceuticals — Aerie Pharmaceuticals, a leading ophthalmic pharmaceuticals company conducting R&D of products for treating patients with glaucoma and other eye diseases.
Show all investments...

Giorgio Anania
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Giorgio has spent more than 30 years in senior management at high-technology companies, from start-up ventures to international public companies, and has led two successful IPOs. He is chairman of Cube Optics AG and vice president of the executive board at Photonics21.Previously, Giorgio was CEO of Bookham, now Oclaro, which he grew from astart-up into a quarter-billion-dollar NASDAQ-listed public company. He also served as the vice president of sales, finance and business development for Flamel Technologies.Prior to that, he was the founder and general manager of the Miniplex DSL Business Unit at Raychem and strategy consultant at Booz Allen.He has a M.A. degree in physics from Oxford University and a Ph.D. in thermonuclear fusion from Princeton University.

Show more...

Investment focus

  • Industry: Medical, Biotechnology
  • Stage:Seed
  • Geography: France

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Show all investments...

Julien Lopizzo
Angel · Lyon, Rhone-Alpes, France · 1 investments in France Biotechnology startups

Julien Lopizzo is the Co-Founder and CEO at Major Corp. He attended Emlyon Business School.

Show more...

Investment focus

  • Industry: Legal Tech, Advertising, Digital Media
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 19
  • Round size: Series A $2.4M–$6.1M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • AirCampus — Amanahtoto adalah air campus bandar darat paling terbaik yang menyediakan toto hongkong asia, jadilah member pertama kali mendaftar dan dapatkan kejutan promonya setiap minggu.
  • Major — Economics & Strategic Intelligence Explorer
  • Keyop Média — Keyop Média développe des titres de presse experts.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Pierre Olivier Goineau
Angel · Lyon, Rhone-Alpes, France · 1 investments in France Biotechnology startups

Pierre Olivier Goineau - President @ Neuronax

Show more...

Investment focus

  • Industry: Medical, Biopharma, Health Care
  • Stage:Venture - Series Unknown
  • Geography: France

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ixaltis — Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.The company was born out of the combined expertise of scientists specialized in urology, pharmaceutical experts and experienced managers: Dr. Philippe Lluel, Christian Chavy, Stefano Palea, Dr. Roberto Gradnik andProfessors Pascal Rischmann and Xavier Gamé. The vision of IXALTIS is to develop treatments for genito-urinary tract diseases with still a high unmet medical need, by identifying drugs which had already reached clinical stage and reexplore these for use in genitourinary tract disorders.IXALTIS has established a proprietary position covering Litoxetine for use in urogenital and other disorders based on its specific mechanism of action.
Show all investments...

Gregoire Delpit
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Gregoire Delpit - Co-founder & COO @ ProcessOut

Show more...

Investment focus

  • Industry: Software, Apps, SaaS
  • Stage:Pre-Seed, Seed
  • Geography: France

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cryptr — DEFAULT : Get features like SSO to convert more B2B customers, regardless of their auth provider. Just a few lines of code to start working with enterprise clients.
  • Qovery — Qovery is a DevOps automation tool that lets developers deploy and scale applications on their cloud by simplifying and automating infrastructure so tech teams can focus on what matters most: building great products.
  • Surge — SurgeCare leverages immune profiling and AI to reveal early immune signatures and drive better decisions in surgery, trauma, infection, and beyond.
Show all investments...

Tom Kemp
Angel · Santa Clara, California, United States · 1 investments in France Biotechnology startups

Tom Kemp is co-founder and Chief Executive Officer of Centrify Corporation, a software and cloud security provider that is the leader in securing enterprise identities against cyberthreats that target today’s hybrid IT environment of cloud, mobile and on-premises. The Centrify Identity Platform protects against the leading point of attack used indata breaches ― compromised credentials — by securing an enterprise’s internal and external users as well as its privileged accounts. Under his leadership Centrify has become one of the fastest growing security vendors in the industry and has amassed over 5000 customers including half of the Fortune 50. Prior to Centrify Kemp held various executive, technical and marketing roles at NetIQ Corporation, Compuware, EcoSystems Software, and Oracle. Mr. Kemp was also an Entrepreneur in Residence at Mayfield, a leading venture capital firm. He is an avid blogger on the Centrify website (http://www.centrify.com/blogs/tomkemp/overview.asp). He holds a Bachelor of Science degree in computer science and in history from the University of Michigan.

Show more...

Investment focus

  • Industry: Cyber Security, Software, Network Security
  • Stage:Seed, Pre-Seed
  • Geography: United States, France, Israel

Investor stats

  • Total investments: 5
  • Round size: Seed $932k–$4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ShareID — Trigger users' identity verification or personal data sharing on demand and in real time through a reusable digital identity
  • SURF SECURITY — Zero Trust browser is an innovative solution that shifts from existing tools like VPN/RBI/CASB/VDI to simplify the security stack and enhance the security.
  • Amplifier Security — Workforce security automation and security copilot for employees
Show all investments...

Sebastien Breteau
Angel · London, England, United Kingdom · 1 investments in France Biotechnology startups

Sebastien Breteau is an entrepreneur, investor, avocado farmer & philanthropist. He is the founder and CEO of QIMA, a global quality and compliance solutions provider for the consumer goods, food, and life sciences industries. Founded in 2005, QIMA partners with 30,000 brands, retailers, manufacturers and food growers globally, helping themmake products consumers can trust with inspections, ESG audits, testing, and certification services. The company has become a leading player, employing over 5,000 people worldwide and operating in over 100 countries (www.qima.com). In 2013, Sebastien founded the Breteau Foundation, a NPO which aims at giving underprivileged children access to digital education. 180,000 children are now enrolled in its program (www.breteaufoundation.org). In 2019, Sebastien founded RayoVerde, and has built one of the biggest avocado farms in Europe (Andalucia, Spain), using the latest organic farming techniques and water needs optimization. Sebastien Breteau is also an active private investor in Europe, China & the US and has invested directly in over 70 start-ups globally.

Show more...

Investment focus

  • Industry: FinTech, Software, Apps
  • Stage:Seed, Series A, Angel
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Seed $500k–$3M; Series A $6.5M–$150M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Ziwig — Ziwig helps to improve women's health through a holistic approach and the development of products, services, and a support ecosystem, guided by science and unique biology. of each person. Their approach, constantly supported by excellent research, is based on the close collaboration of medical experts and engineers specializing in cutting-edgetechnologies, such as artificial intelligence and high-throughput sequencing of human RNAs. Their ecosystem functioning, driven by meaning and centered on the person, using disruptive technologies contributes to the emergence of precision medicine, individualized, predictive and participatory, at the service of well-being and quality of life.
  • REWORTH — En Reworth conectamos a instituciones financieras y comercios para ofrecer a los consumidores el programa de cashback personalizado mas efectivo.
  • Sundayapp — Our solution is the world's fastest and easiest way to pay at restaurants. Your customers scan a QR code and pay in 10 seconds
Show all investments...

David Lamond
Angel · 1 investments in France Biotechnology startups

David Lamond

Show more...

Investment focus

  • Industry: Retail, Genetics, E-Commerce
  • Stage:Series A
  • Geography: France, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
  • Dopple — Dopple is a retail e-commerce platform that offers children's clothing to reach today’s savvy parents. Dopple uses a personalized quiz, rich behavioral data, and machine learning to deliver a quarterly “Dopple Drop” of custom-curated outfits to their door.Dopple is the trusted partner for childrenswear brands, including Stella McCartneyKids, Chloé, Versace, Petit Bateau, Vilebrequin, Lele Sadoughi, Rylee + Cru, Bobo Choses, Dôen, Andy & Evan, Tea Collection, and over 200+ other brands. By partnering with Dopple, these brands acquire and retain customers, monetize past- and current-season merchandise without brand dilution, nimbly scale logistics and collect unparalleled consumer insights.
Show all investments...

David Helgason
Angel · Copenhagen, Hovedstaden, Denmark · 1 investments in France Biotechnology startups

David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do.David's background is inprogramming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.

Show more...

Investment focus

  • Industry: Software, Gaming, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Denmark, Finland

Investor stats

  • Total investments: 81
  • Round size: Seed $1M–$8.3M; Pre-Seed $242k–$2.4M; Series A $5.4M–$30M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • ScyAI — Risk intelligence that thinks with you.
  • Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
  • Flow Engineering — Requirements management, made collaborative
Show all investments...

Olivier Duha
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Olivier Duha created Webhelp with Frederic Jousset in 2000. The company began as a “webwizard” service, where specially trained advisors provided online support to novice internet users. Just 16 years later, Webhelp is one of the leading global BPOs.Olivier is a graduate of ESCEM (Ecole Superieure de Commerce et Management) and AUDENCIA BusinessSchool, where he gained a Masters in Management Consultancy. In 1998 Olivier was awarded an MBA from INSEAD.Starting his career in 1992 with LEK Consultancy, a strategy, mergers and acquisitions firm, Olivier was based in London, Paris and Sydney and advised business leaders in a range of industries.In 1998, he joined American strategic consulting firm Bain & Company, where he worked on various projects in the retail and energy sectors. Olivier also worked on a major internet development strategies for large industrial groups.Olivier served four years as vice president and two years as president of Croissance Plus, a non-profit association of start-ups and fast growing companies. During this time he actively campaigned for a more entrepreneurial framework in France, writing a number of reports and white papers and participating in a number of debates with successive governments.Olivier is also a member of the Mouvement des Entreprises de France (MEDEF), France’s largest employer’s federation.In 2012, Olivier co-founded AlterEquity 3P and raised 50 million euros of investment to finance social and environmental projects. AlterEquity is France’s largest investment fund, fully dedicated to socially responsible businesses. Olivier also serves on the boards of a number of start-ups in a large variety of industries.Olivier has five children, is a Knight of the Order of Merit and a graduate of the Wine and Spirit Education Trust.

Show more...

Investment focus

  • Industry: FinTech, Insurance, Consulting
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 4
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • +Simple — +Simple.fr is an insurance Robo-Broker for freelancers, small and medium businesses. Its unique technology platform optimizes your insurance for the duration of your contracts. The algorithm personalizes the offers according to your activity and its evolution.
  • InnovaFeed — InnovaFeed is a biotech company that produces a new source of protein from insect rearing (Hermetia illucens) for animal feed and aquaculture in particular.Their model is based on a unique technological expertise that allows us to place the insect at the heart of their agri-food system and restore it to its natural place in their ecosystem: thatof recycling nutrients to then feed fish, birds or small mammals.In the context of a fast-growing world population, InnovaFeed’s activity responds concretely and competitively to an increase in protein demand while contributing to the development of a more sustainable food system, in particular through the development of quality aquaculture.
  • iVESTA Family Office — iVESTA Family Office is designed for entrepreneurs that offer a resolutely entrepreneurial approach so that its clients can manage their assets as they manage their company with the same requirement of strategic planning, discernment, and anticipation. They build a global wealth strategy implemented with the greatest discipline.
Show all investments...

Christophe Cervasel
Angel · 1 investments in France Biotechnology startups

Christophe Cervasel

Show more...

Investment focus

  • Industry: Farming, Medical, Wellness
  • Stage:Seed
  • Geography: France

Investor stats

  • Total investments: 2
  • Round size: Seed $1.3M–$1.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • nextProtein — nextProtein is developing a large scale and sustainable insect based source of protein. The bioconversion of fly larvae fed with organic waste generates valuable feed components for fish, livestock and pets.
  • Urgence Docteurs — UrgenceDocteurs is a brand new application. A study shows that 20,000 to 30,000 doctors do not practice in France. Which does not help anyone else Everyone is constantly looking for doctors. Whatever the position of the practitioner: general practitioner, pediatrician, physiotherapist, nurse, osteopath or carer, allows all these professionals todevelop their activity with a minimum of constraints! UrgenceDocteurs has been thought to meet the needs of physicians, who, even with long years of study, do not have the opportunity to leverage their expertise. While medicine studies are very difficult, each year, nearly 25% of thesed doctors do not settle. that 20,000 to 30,000 doctors do not practice in France. Lack of social protection, high installation costs, unsuitable premises or the fear of the administrative are all arguments put forward to explain this observation.
Show all investments...

Eric Carreel
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Eric started his career in institutional research as a researcher in the field of radio.He then co-founded Inventel and remained its President from 2002 to 2005, being recognised as one of the major architects of Triple Play in Europe. After Thomson bought Inventel, Eric became technical director of Thomson's domestic products divisionwhile creating and managing the Advanced Product Development group.Eric is an Engineer from the Industrial Physics & Chemistry Grande Ecole in Paris (ESPCI) and has a PhD in engineering from the University of Paris VI. He is the author of over fifty patents and directs the vision and innovation at Withings.

Show more...

Investment focus

  • Industry: Data Center, Electronics, Data Storage
  • Stage:Seed, Pre-Seed, Series A
  • Geography: France

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
  • Fifteen — AkongCuan menghadirkan portal blog toto online serta link login bandar slot gacor resmi 2026 dengan sistem aman dan update terbaru setiap hari.
  • Spore.Bio — Lighting up microbiology
Show all investments...

Alain Tingaud
Angel · Saint-astier, Aquitaine, France · 1 investments in France Biotechnology startups

Alain Tingaud is a Founder & CEO at Alain Tingaud Innovations.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Cryptocurrency
  • Stage:Pre-Seed, Seed
  • Geography: France, Luxembourg, United States

Investor stats

  • Total investments: 5
  • Round size: Seed $1.5M–$5M; Pre-Seed $1.1M–$1.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Gonuggets — We help digitally native brands to grow their e-commerce revenue on marketplaces such as Amazon and D2C across EMEA.
  • MarketLeap — Breaking E-commerce Barriers with Software. MarketLeap is managing all the complexities of selling and growing on marketplaces worldwide.
  • Trendex — Trendex is a YC-backed, fast-growing tech startup working with the world's most famous and most promising athletes to build new revenue streams and engagement opportunities for talents and fans around the world...
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Maxime Hurtebize
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Maxime Hurtebize is an Investment Officer - Financial Institutions at PROPARCO. He attended emlyon business school.

Show more...

Investment focus

  • Industry: CleanTech, Electronics, Health Care
  • Stage:Seed
  • Geography: France

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Glowee — Glowee is engaged in the development of biological light systems using the natural properties bioluminescent marine organisms. Requiring neither electricity nor installation infrastructure, these systems are built by encoding particular genes in symbiotic bacteria.
  • WiSEED — Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
  • YMoney — YMoney develops digital payment solutions for people that enable them to make instant payments within their mobile phones. They offer card payment, account transfer, API collection, and wallet payment services, enabling clients to transfer money online through laptops, smartphones, or any other digital mode.
Show all investments...

Charles-Edouard Bouee
Angel · Munich, Bayern, Germany · 1 investments in France Biotechnology startups

Charles-Edouard Bouée is the CEO of Roland Berger. He is a seasoned expert in reorganization, post-merger projects and integration programs, as well as performance improvement, and specializes in disruptive innovation, new technologies and digital transformation.Charles-Edouard Bouée joined Roland Berger in 2001 as Senior Partner in the Parisoffice, where he headed the Financial Services and Energy & Utility Competence Centers. He became the Managing Partner of Roland Berger’s China office in 2006 and Head of the Asia Leadership Team in 2009.He then assumed responsibility for France, Belgium, Italy, Spain and Morocco. He has since fulfilled consulting mandates for leading international companies and organizations based in Europe, Asia and elsewhere. Charles-Edouard Bouée was appointed COO in July 2013 and elected CEO of Roland Berger in June 2014.Charles-Edouard Bouée has authored various books on modern management and China, as well as Artificial Intelligence.

Show more...

Investment focus

  • Industry: Biotechnology, Natural Resources, AgTech
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United States, France, Vietnam

Investor stats

  • Total investments: 5
  • Round size: Pre-Seed $348k–$1.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • xRapid — xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence. xRapid is a Biotech startup based in Aix en Provence (France), London (Uk), and Las Vegas. xRapid saw its beginnings in a laboratory in Jakarta. Their CTO, Professor David Mendels, recognized that he was able to develop a mobilesolution for malaria diagnosis after attending a conference. Since then he has created xRapid, a powerful automated test that can be deployed anywhere in the field and has the potential to spot other diseases from tuberculosis to gonorrhea.
  • PaySika — Un compte, une carte bancaire gratuite
  • INTERSTELLAR LAB — Interstellar Lab is a biotech company founded in 2018 that develops, manufactures and operates advanced bio-farming platforms to help its customer produce the cleanest plant-based ingredients. Its bio-farming technology combines automated farms (Biopods), AI and bioscience with a unique data-driven approach. Its considerably accelerates plantgrowth while optimizing plant molecular composition. Interstellar Lab provides sustainable plant-based ingredient solutions to large health, beauty and F&B companies. Its bio-farming technology has also convinced NASA and ESA, which contracted with the company to adapt the system for space deployment. The company counts 45 engineers, scientists and researchers located between its flagship 65,000SF BioPod Facility and Plant Lab in Ivry-sur-Seine (France), its SpaceLab at NASA KSC Florida (USA) and its Business Hub in San Francisco (USA).
Show all investments...

Lara Nuchowicz
Angel · New York, New York, United States · 1 investments in France Biotechnology startups

Lara Nuchowicz

Show more...

Investment focus

  • Industry: Biotechnology, Product Research, Consumer Research
  • Stage:Pre-Seed
  • Geography: France

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amatera — Amatera is a biotechnology research company that leverages the latest techniques in biotechnology, to create coffee varieties. Amatera urges to make coffee varieties more sustainable and climate resistant to fill that massive demand. Founded by Omar Dekkiche and Lucie Kriegshauser in 2022 and is located in Paris, France.
Show all investments...

Andreï Polukhtin
Angel · 1 investments in France Biotechnology startups

Andreï Polukhtin

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology
  • Geography: France

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • C4Diagnostics — Dana69 adalah tempat penyedia link login game online yang bisa di mainkan dengan menggunakan smartphone android dan iphone dan bisa melakukan top up slot dana 10k atau slot deposit dana 10k selalu online 24 jam.
Show all investments...

Fidji Simo
Angel · Palo Alto, California, United States · 1 investments in France Biotechnology startups

Fidji Simo is the CEO and Chair of the Board of Directors of Instacart. She previously worked at Facebook as a Head of the Facebook App. Fidji Simo attended HEC Paris.

Show more...

Investment focus

  • Industry: Software, Health Care, Internet
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 23
  • Round size: Seed $1.2M–$12M; Series A $10M–$48M; Series B $28M–$250M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Breezy — Breezy is a mobile-first AI workspace for real estate agents that provides virtual assistant services and CRM systems for realtors and brokerages.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
  • Beacon Software — Beacon acquires and grows essential businesses with permanent capital and a centralized operating platform.
Show all investments...

Cyril Grislain
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Cyril Grislain - Board advisor @ Smart Me Up

Show more...

Investment focus

  • Industry: Big Data, Software, Artificial Intelligence
  • Stage:Series A, Seed, Angel
  • Geography: France

Investor stats

  • Total investments: 7
  • Round size: Seed $1.4M–$1.8M; Series A $1.3M–$9.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Visiblee — Visiblee is a generation automation solution to boost B2B website conversion.VA first worldwide, Visiblee Lead Generation solution identifies individual website visitors. It enables Sales Teams to increase their sales by transforming anonymous website visitors into qualified leads.Visiblee is develped by Salezeo, which has its main office inParis and is also active in the UK and in Spain.
  • nextProtein — nextProtein is developing a large scale and sustainable insect based source of protein. The bioconversion of fly larvae fed with organic waste generates valuable feed components for fish, livestock and pets.
  • Foxintelligence — Discover key insights into digital purchasing trends with NielsenIQ. Enhance your strategy with our data. Explore now!
Show all investments...

Arthur Waller
Angel · Amsterdam, Noord-Holland, The Netherlands · 1 investments in France Biotechnology startups

Arthur Waller is a co-founder of PriceMatch, a start-up aiming to industrialize and democratize yield management.Arthur studied economics and econometrics at Ecole polytechnique and Sciences Po. He first worked in economic research at the IMF and at Goldman Sachs before creating his start-up, PriceMatch, with some friends. Using theirskills in economics, econometrics, software engineering, they developed a SaaS platform offering revenue management solutions to companies.

Show more...

Investment focus

  • Industry: Software, FinTech, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: France, Spain, United States

Investor stats

  • Total investments: 22
  • Round size: Seed $2.4M–$7.5M; Pre-Seed $1.4M–$3.4M; Series A $3.3M–$21M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Spiko — Spiko is a tokenization platform that offers to be the supplier of tokenized Money Market Funds.
  • RockFi — RockFi is a private management company offering wealth management services.
  • Piston — AI-native ERP for manufacturers, food & beverage producers, and distributors. Built-in dashboards, Ask, and agents that run your operations end-to-end.
Show all investments...

Rajat Khare
Angel · 1 investments in France Biotechnology startups

An Internet-age investor and a serial entrepreneur, Rajat Khare is the founder of the European (luxembourg based) investment firm -Boundary Holding. A prominent investment fund with presence in France and Luxembourg, Boundary Holding invests globally in spaces related to Artificial Intelligence (AI) and allied fields such as Data Analytics andMining, Machine learning and Predictive Analytics.Each field contributes significantly to the development of various industries. Data Analytics optimizes business decisions, enhances healthcare, and fortifies cybersecurity. Machine Learning propels autonomy, refines user experiences, and advances predictive maintenance. Predictive Analytics revolutionizes finance, streamlines supply chains, improves healthcare, and tailors customer relations.Boundary Holding primarily acts as a Bridge fund for startups and organizations, facilitating funds across Safe cities, Internet of Things, Algorithmic trading, AI and Analytics. The company has a network of startup programs around the world.Rajat khare holds a Computer Science degree from IIT-Delhi, and has interned at RUCA, University of Antwerp in the Department of Mathematics. He has been a keynote speaker in over 20 major conferences and events across the globe. His work as an investor has also been cited as a case study in the course of Entrepreneurship run by Professor Patrick Turner in INSEAD Business School. He has authored various research papers published in international conferences and books, such as Data Mining V by WIT press. Rajat has co-authored Make the Move on entrepreneurship and Science of Achievement on education. Both the books reflect Rajat’s inclination towards promoting entrepreneurship and a holistic incubation of innovative solutions around the world.An active member of The Indus Entrepreneurs (TIE), the IIT Delhi alumni association and the Indian angel network, Rajat proactively supports and encourages entrepreneurs and entrepreneurial ventures around the world. For his efforts to promote entrepreneurship, he was appreciated by Dr APJ Abdul Kalam at the President’s house in 2006, spotlighting his significant role in promoting entrepreneurship on a global scale.

Show more...

Investment focus

  • Industry: Drones, Aerospace, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: France, Switzerland, Germany

Investor stats

  • Total investments: 23
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
  • Scewo — Scewo is a medical technology platform that develops stair-climbing wheelchair. Founded in 2017, the company is headquartered in Winterthur, Zurich, Switzerland.
  • EdallSystems — EdallSystems provide Educational Service (Aerospace Engineering Training), UAV development, Engineering Service(Lab Development) and consulting in INDIA. Their moto is to become a major Product Development company in the filed of Aerospace In India and to support and Develope Aerospace products in India.
Show all investments...

Khaled Helioui
Angel · Hamburg, Hamburg, Germany · 1 investments in France Biotechnology startups

Khaled Helioui is a Partner at Plural, an early stage investment firm founded & led by entrepreneurs. We invest serious time & early stage venture capital to back the next generation of iconic founders. Plural lead investors have the scar tissue & reach to best support founders & tilt the odds for them to build legendary companiesthat can have a GDP-level impact in Europe, tackle systemic risks & address opportunity gap.

Show more...

Investment focus

  • Industry: Information Technology, Internet, Software
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 26
  • Round size: Seed $1.4M–$25M; Series A $7M–$40M; Series B $22M–$158M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Mos — Meet Mos: the way smart students get money for college
  • Cardless — Cardless provides a platform for businesses to launch and manage integrated credit card experiences. The service includes application processing, customer support, and account management, ensuring a seamless experience for users.
  • Numerade — Ace can instantly respond to text, uploaded notes, quizzes, worksheets and summarize to help you Ace your exams.
Show all investments...

Fabio Mondini de Focatiis
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Venture Partner, Eurazeo InvestmentInternational Venture Capitalist, Business Angel and SVP with >20 years experience in >20 countries, with a successful track as VC, BA and Entrepreneur in a truly global environment. Fabio is a Venture Partner in Eurazeo Investment, following their acquisition of IDINVEST Partners, a leading Europeanprivate equity firm with >9B€ AUM, focusing on Venture Capital investments in Italy across sectors and in the Smart City sector (Energy, Cleantech, Eco-mobility) worldwide. Fabio is the Founder and CEO of growth Capital, the leading Italian investment banking focusing on advising innovative, fast-growing companies on fund raising and M&A. Fabio is also an active Business Angel, with a personal portfolio of more than 30 startups. a Member of the Investment Committee of Lazio Innova. Previously Fabio has been a Senior Advisor in the European Investment Fund (EIF), leading the joint efforts of EIF and Cassa Depositi e Prestiti (CDP) to establish TT Investment Funds in Italy to develop its ecosystem for Innovation. Before entering the Private Equity sector, Fabio has lead Soitec Solar Division sale after it has increased its revenues from ~2M€ to >40M€ and achieved the world record of PV Module Efficiency and Solar Cell Efficiency. He had earlier founded and lead RenEn Renewable Energy to a leading renewable energy consulting firm. Earlier Fabio has been in McKinsey, ENEL and Russell Reynolds. In ENEL, Fabio has been Head of Integration, Head of International Management, Head of HR and Organisation and member of the Board of various international companies. Fabio received his M.S. degree in Civil and Environmental Engineering from M.I.T. and his M.B.A. from INSEAD. He is fluent in English, Italian, French and Spanish.

Show more...

Investment focus

  • Industry: E-Commerce, Retail, Internet
  • Stage:Seed, Pre-Seed, Equity Crowdfunding
  • Geography: Italy, France, United Kingdom

Investor stats

  • Total investments: 22
  • Round size: Seed $318k–$2.2M; Equity Crowdfunding $1.4M–$3.3M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Homepal — Homepal, a digital real estate agency, allows owners and buyers to make direct contact and independently organize visits to the house. It is also a site to buy, sell, and rent a house with the full support of a real estate agency, at low costs. The team of the Homepal RE real estate agency will then help in managing the negotiations and thecontracts.It was founded in 2015 and is headquartered in Italy.
  • HiNelson — HiNelson an Italian-based online store for nautical accessories. HiNelson is the first nautical online store about high-level boating components. They select the best and successful brands in the nautical worldwide market, such as Veleria San Giorgio to guarantee maritime safety with their life jackets, moving through Polyform’s boat fenders foryacht protection, or the best anchoring and docking system by Lofrans’, Max Power and Quick and finishing with the most famous Plastimo’s compasses or and Bartomarine sail’s accessories.
  • Yobs — Record your interviews, accelerate candidate review, coach recruiters and build a fair and rigorous hiring process.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Rémi Gaston- Dreyfus
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Rémi Gaston- Dreyfus

Show more...

Investment focus

  • Industry: Medical, Biotechnology
  • Stage:Seed
  • Geography: France

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Show all investments...

Jean-Paul Kress
Angel · Boston, Massachusetts, United States · 1 investments in France Biotechnology startups

Jean-Paul Kress is based out of Paris, Île-de-France and is the Chief Executive Officer and Chairman of the Board of Vor Biopharma and Independent Director of Sanofi. Jean-Paul previously worked at MorphoSys as a CEO. Jean-Paul Kress attended the Université de Paris.

Show more...

Investment focus

  • Industry: Medical, Biotechnology
  • Stage:Seed
  • Geography: France

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • LinKinVax — As part of our strategic evolution, EnnoDC has become the new trading name of LinKinVax. We're expanding our dendritic cell targeting technology and
Show all investments...

Guillaume Amblard
Angel · London, England, United Kingdom · 1 investments in France Biotechnology startups

Guillaume Amblard

Show more...

Investment focus

  • Industry: Software, Banking, FinTech
  • Stage:Seed, Series A
  • Geography: France, United Kingdom, Tunisia

Investor stats

  • Total investments: 11
  • Round size: Seed $630k–$9M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Uptale — Uptale provides an enterprise solution that enhances employee learning through immersive experiences in 360° and virtual reality. The platform allows organizations to create, share, and analyze training modules without requiring technical expertise.
  • Wattnow — Wattnow is a real-time monitoring solution that provides a breakdown of energy spending to identify wasteful trends.
  • Thunder Code — Transform your QA process with Thunder Code's AI-powered test automation platform. Create, manage, and run automated tests without coding - perfect for QA teams seeking efficiency, reliability, and seamless integration.
Show all investments...

Alexandre Prot
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Alexandre Prot is based out of Paris, Île-de-France and is the Co-Founder and CEO of Qonto. Alexandre previously worked at Smartven as a Co Founder. Alexandre Prot attended the HEC Paris.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Banking
  • Stage:Seed, Series A, Series B
  • Geography: France, Singapore, Switzerland

Investor stats

  • Total investments: 12
  • Round size: Seed $1.1M–$14M; Series A $8.8M–$30M; Series B $29M–$58M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Flowdesk — The new standard for market-making and crypto-financial technology. Market-making as a Service, brokerage, custody of cryptocurrencies.
  • Silvr — Silvr reinvents the way entrepreneurs get funded.Financing businesses has not evolved over the last decades: banks prefer to fund assets, equity is not the best fit for all. At Silvr, we empower entrepreneurs by building a world where funding is easy to access, scalable, and equity-free. We leverage digital businesses data to predict futurerevenues and offer funding in 24 hours.We are headquartered in Paris, are backed by ISAI and Eurazeo and we deploy millions of euros of funding for European entrepreneurs every month.
  • Numeral — Numeral enables financial institutions, tech companies, and corporates to scale bank integrations and payment operations with a single API.
Show all investments...

Bertrand Jelensperger
Angel · Paris, Ile-de-France, France · 1 investments in France Biotechnology startups

Bertrand Jelensperger is the Co-Founder and Advisory Board at TheFork.

Show more...

Investment focus

  • Industry: Apps, Software, E-Commerce
  • Stage:Seed, Series A, Angel
  • Geography: France, Spain, Belgium

Investor stats

  • Total investments: 15
  • Round size: Seed $1.1M–$7.7M; Angel $1M–$2.7M; Series A $4.4M–$11M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Malou — Malou offers food marketing and digital marketing solutions for restaurants. The company also offers content management, restaurant marketing, reputation management, presence management, and SEO solutions.
  • Kiliba — 100% automated emailing platform: design of html templates in your colours, sending of personalised emails, marketing automation workflows, enriched CRM
  • Neptune Elements — Neptune Elements offerFrench seaweed of controlled origin, with exceptional taste and culture.
Show all investments...

Jacques Lewiner
Angel · 1 investments in France Biotechnology startups

Jacques Lewiner - Member of the Board of Directors @ Axilum Robotics

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Series C
  • Geography: France

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Cytoo — Pioneering muscle pathology research with our exclusive MyoScreen platform to accelerate drug target identification and therapeutic innovation.
  • Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Show all investments...

Jacques Gardette
Angel · 1 investments in France Biotechnology startups

Jacques Gardette is the Founder & President of Brenus Pharma.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Medical Device
  • Stage:Series A
  • Geography: France

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • SURGAR — SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery.
  • Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
Show all investments...

Bashar Hamood
Angel · 1 investments in France Biotechnology startups, 9 in the past 12 months

Bashar Hamood is a Venture Partner at FasterCapital. He previously worked as an Associate Director at Logica. He attended Heriot-Watt University.

Show more...

Investment focus

  • Industry: Information Technology, Software, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Nigeria, United Kingdom

Investor stats

  • Total investments: 323
  • Lead/follow: no public data

Portfolio highlights

  • EcoBites — EcoBites is a subscription service that delivers sustainably sourced and eco-friendly packaged snacks and meals to consumers doorsteps.
  • Lawyeree — A platform offering AI legal advice to clients and allowing clients to be connected with the best lawyers.
  • SafeNest — SafeNest offers a comprehensive home security system integrating smart technology with professional monitoring services.
Show all investments...

Stephane Legastelois
Angel · 1 investments in France Biotechnology startups

Stephane Legastelois is a President at 33 Californie

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical
  • Stage:Series A
  • Geography: France

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Brenus Pharma — Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment.
Show all investments...

Geoffroy Roux de Bezieux
Angel · Levallois-perret, Ile-de-France, France · 1 investments in France Biotechnology startups

Geoffroy Roux de Bezieux is the Founder and President of Notus Technologies. He previously worked at Groupe PSA as a Vice-Chairman of the Supervisory Board.

Show more...

Investment focus

  • Industry: Software, Mobile Apps, Real Estate
  • Stage:Seed, Series A, Pre-Seed
  • Geography: France

Investor stats

  • Total investments: 7
  • Round size: Series A $2.8M–$5.3M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Greenly — With Greenly's Carbon Management's platform; measure, reduce, report and offset your carbon emissions for a cleaner future!
  • Okarito — Okarito is an online platform helping companies organize, monitor and optimize their business travel. On Okarito, the traveler can book his travel and has access to a personalised support during his trip. We also help the CFO to regain control on his travel expenses thanks to innovative tools. He can set up a dynamic travel budget that adapts inreal time to market prices. Therefore he controls the travel options offered to travelers while giving them an increased flexibility. The employee is motivated to spend less than the given budget. A share of the savings he makes can be donated to a NGO of her choosing.
  • Homepilot — We revolutionize residential property management through the use of technology.
Show all investments...

Biotechnology Angel investor funding in France at a glance

Stats across 63 deals from 90 investors.

90
investors
in France Biotechnology startups
63
deals
in France Biotechnology startups
$6.6M
median round
in France Biotechnology startups
10%
lead investors
lead at least one round
43%
Seed
most common funding stage

Access all 90 angel investors in France Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 90 angel investors investing in France Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists